Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 3376 AL 3390

Neurofilament light chain in Alzheimer's disease

Fuloria NK, Sekar M, Porwal O, Ansari MT, Biswas A, Narain K, Biswas S, Bhatia S, Dhanalekshmi UM, Fuloria S.

Clin Chim Acta. 2026 Jan 1;578:120580. doi: 10.1016/j.cca.2025.120580. Epub 2025 Aug 30.

The Biomarker Profile of Alzheimer's Disease for Disease-Modifying Treatment Eligibility: Questions and Debates

Athanasaki A, Tsantzali I, Theodorou A, Michalopoulou A, Constantinides VC, Boufidou F, Tzartos JS, Tsalouchidou PE, Zompola C, Paraskevas SG, Bonakis A, Giannopoulos S, Tsivgoulis G, Kapaki E, Paraskevas GP.

Int J Mol Sci. 2025 Sep 29;26(19):9531. doi: 10.3390/ijms26199531.

Overview of Proteomic Analysis of Amyloid Plaques and Neurofibrillary Tangles in Alzheimer's Disease

Grewal A, Raikundalia S, Zaia J, Sethi MK.

Biomolecules. 2025 Sep 11;15(9):1310. doi: 10.3390/biom15091310.

The Inflammatory Nexus: Unraveling Shared Pathways and Promising Treatments in Alzheimer's Disease and Schizophrenia

Russo AP, Pastorello Y, Dénes L, Brînzaniuc K, Krupinski J, Slevin M.

Int J Mol Sci. 2025 Jun 27;26(13):6237. doi: 10.3390/ijms26136237.

Potential diagnostic markers in Alzheimer's disease: current perspectives and future directions

Zheng M, Wang S, Jia J.

Neurodegener Dis Manag. 2026 Apr;16(2):225-237. doi: 10.1080/17582024.2025.2554515. Epub 2025 Sep 5.

Exosomal microRNA biomarkers in Alzheimer's disease: Systematic review and meta-analysis

Liu S, Zhao M, Yang X, Liu Y, Xu H, Yan H, Xu Y.

Clin Chim Acta. 2026 Jan 1;578:120542. doi: 10.1016/j.cca.2025.120542. Epub 2025 Aug 7.

On the complexity of biomarker-driven diagnoses of Alzheimer's disease

Grasso SM, Santos-Santos MÁ, Clark AL.

J Neuropsychol. 2025 Jun;19(2):176-185. doi: 10.1111/jnp.12428. Epub 2025 May 2.

Alzheimer's Disease Diagnosis in the Preclinical Stage: Normal Aging or Dementia

Marvi F, Chen YH, Sawan M.

IEEE Rev Biomed Eng. 2025;18:74-92. doi: 10.1109/RBME.2024.3376835. Epub 2025 Jan 28.

Blood plasma proteomic markers of Alzheimer's disease, current status and application prospects

Strelnikova PA, Zakharova NV, Kononikhin AS, Bugrova AE, Indeykina MI, Mitkevich VA, Makarov AA, Nikolaev EN.

Expert Rev Proteomics. 2025 Jan;22(1):11-18. doi: 10.1080/14789450.2025.2450804. Epub 2025 Jan 29.

"Advances in biomarker discovery and diagnostics for alzheimer's disease"

Bhatia V, Chandel A, Minhas Y, Kushawaha SK.

Neurol Sci. 2025 Jun;46(6):2419-2436. doi: 10.1007/s10072-025-08023-y. Epub 2025 Feb 1.

[Current Status and Future Perspectives of Biomarkers in Alzheimer's Disease Diagnosis]

Ishiguro T, Kasuga K.

No Shinkei Geka. 2025 Sep;53(5):923-931. doi: 10.11477/mf.030126030530050923.

Research Progress on Alzheimer's Disease Biomarkers Based on the ATX(N) Framework

Cao H, Zhang W, Lin J, Yu E.

Discov Med. 2025 Feb;37(193):258-275. doi: 10.24976/Discov.Med.202537193.21.

Advanced biomarkers: Beyond amyloid and tau: Emerging non-traditional biomarkers for alzheimer`s diagnosis and progression

Afrin MR, Upadhyaya PG, Hashim A, Bhattacharya K, Chanu NR, Das D, Khanal P, Deka S.

Ageing Res Rev. 2025 Jun;108:102736. doi: 10.1016/j.arr.2025.102736. Epub 2025 Mar 22.

Alzheimer's disease biomarkers and their current use in clinical research and practice

Hunter TR, Santos LE, Tovar-Moll F, De Felice FG.

Mol Psychiatry. 2025 Jan;30(1):272-284. doi: 10.1038/s41380-024-02709-z. Epub 2024 Sep 4.

Mapping Alzheimer's disease heterogeneity with molecular imaging biomarkers

Harput E, Boccalini C, Mathoux G, Prior JO, Testart N, Jreige M, Garibotto V.

Eur J Clin Invest. 2026 Jan;56(1):e70163. doi: 10.1111/eci.70163. Epub 2025 Dec 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias